Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
This funding opportunity supports research into how certain diabetes medications may influence cancer risk, encouraging studies that explore the underlying biological mechanisms involved.
Contact for amount
Closed
Nationwide
Key Dates
Application Opens
August 23, 2023
Application Closes
November 17, 2024
Contact Information
Grantor
NIH Grants Information
Subscribe to view contact details
Newsletter Required
Categories
Education
Health
